Biotechnology

The wellness brand is shifting gut care from a quick fix to a daily ritual with a new product line and a savvy digital strategy targeting modern consumers.

A year-long Texas trial shows a new biosurfactant boosts oil recovery by 15% with a massive ROI, signaling a major shift in fracking chemistry.

With its latest purchase, Harbor IT expands into the Southeast, targeting life sciences and manufacturing with a highly specialized service model.

Dr. Craig Tendler's move to Predicta Biosciences signals a major shift, blending pharma expertise with biotech innovation to revolutionize cancer care.

With a new CCO and advanced T-Body™ platform, Invenra is shifting from R&D to aggressive commercialization. Can it dominate the multispecific antibody market?

With new CMO Anisha Raghavan, the science-heavy supplement brand plans to translate its complex clinical research into mainstream consumer success.

A new collaboration between the digital health giant and a top cancer center aims to deliver expert insights to doctors worldwide, tackling a complex field.

The cancer center's prestigious FACT accreditation for bone marrow transplants brings world-class blood cancer treatment closer to home for patients in Georgia.

Paris-based Ennov lands a major transatlantic investment to accelerate its AI platform, aiming to reshape global drug development and regulatory processes.

A novel drug is in clinical trials for depression, moving beyond neurotransmitters to target the brain's fundamental energy production and repair mechanisms.

ZoomRx's new AI operating system, Sagan Agents, promises to slash market research timelines from weeks to days, reshaping strategic insights for biopharma.

Massachusetts has approved a groundbreaking on-site technology that turns hazardous medical waste into recyclable material, disrupting the traditional disposal industry.

A new partnership embeds Eli Lilly's powerful AI models into CDD Vault, giving smaller biotechs unprecedented access to big pharma's discovery tools.

A new clinical trial is testing a device that uses electricity to deliver chemo directly into tumors, a strategy that could revolutionize treatment.

IGI announces ISB 2301, a first-in-class antibody targeting three tumor antigens and activating both T and NK cells for a new assault on solid tumors.

Mispro's new contract vivarium at Genesis Science Center aims to provide crucial, flexible lab space for San Diego's burgeoning biotech startups.

The 12th Annual Ride of Hope adds new challenging routes to honor Terry's legacy, channeling funds into cutting-edge precision cancer research.

A new purpose-built lab, Toronto's first in 20 years, attracts a major cell therapy firm, signaling a turning point for Canada's life sciences sector.

A first-in-class drug for anxiety has entered patient trials, offering a novel approach that could reshape mental healthcare for millions.

Two specialist investors are merging to create the world's largest dedicated healthcare fund, aiming to reshape global health innovation from West to East.